Profile
VAXX VRTX REGN VRNA ARGX ALNY
Company Name Vaxxinity, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $2.19M $122.53B $81.62B $72.68B $50.22B $43.35B
Employees 0.06K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Mei Mei Hu Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
VAXX VRTX REGN VRNA ARGX ALNY
Quant Rating Score 1 4 4 1 4 3
Quant Rating Strong Sell Buy Buy Strong Sell Buy Neutral
Trading
VAXX VRTX REGN VRNA ARGX ALNY
Last Close $0.0001 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $0.05 $513.76 $788 $106.91 $929.61 $491.09
Low 52 - $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -99.8 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 0 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
VAXX VRTX REGN VRNA ARGX ALNY
1 Month Return -90 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return 0 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return -99.33 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return 0 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return -98 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return -50 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
VAXX VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -71.28 % 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Growth
VAXX VRTX REGN VRNA ARGX ALNY
Asset Growth -58.35 % 7.41 % 53.91 % 10.71 %
Gross Profit Growth -32.66 % 1.16 % - 26.81 %
Revenue Growth - 0.99 % - 22.97 %
Revenue 3 Year -100 % 20.64 % -15.89 % 147.1 %
Revenue 5 Year - 73.64 % - 775.72 %
Revenue 10 Year - 285.02 % - 2487.4 %
EBIT Growth 24.72 % 9.09 % -131.37 % 24.59 %
Net Income Growth 99.92 % 2.09 % -224.78 % 36.82 %
Net Income 3 Yeari Growth Per Share 99.86 % 6.32 % -148.34 % 69.73 %
Net Income 5 Yeari Growth Per Share 99.6 % 31.91 % 25.82 % 73.13 %
Net Income 10 Yeari Growth Per Share 99.6 % 680.22 % -35.51 % 55.09 %
Operating Income Growth 23.29 % -7.46 % -133.02 % 37.31 %
Operating Cash Flow Growth (CFG) -2.34 % - -143.33 % -107.98 %
Operating 3 Year CFG -67.39 % -100 % -170.73 % 98.8 %
Operating 5 Year CFG -362.78 % -100 % 54.81 % 97.44 %
Operating 10 Year CFG -362.78 % -100 % 40.15 % 97.08 %
EPS Growth 99.92 % 5.31 % -214.81 % 38.07 %
EPS Diluted Growth 99.92 % 8.19 % -208.93 % 38.07 %
Book Value Per Share -78.53 % 32.88 % -22.82 % 129.75 %
Share Holder 3 Year Equity Growth Per Share 115.22 % 41.21 % 1.82 % -89.42 %
Share Holder 5 Year Equity Growth Per Share 127.41 % 191.63 % -24.45 % -96.01 %
Share Holder 10 Year Equity Growth Per Share 127.41 % 842.11 % -71.86 % -95.83 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share - - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share - - - -
Debt Growth 4.25 % 0.06 % 139.05 % 110.16 %
Free Cash Flow Growth -0.43 % - -144.48 % -201.54 %
Updated On 31 Dec 2023 31 Dec 2025 31 Dec 2024 31 Dec 2024
Profitability
VAXX VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM - 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -0.13 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -0.15 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -218.25 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 100 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 0.1 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM - 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -377.36 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM - 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM 1.25 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM - 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM - 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -0.45 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -0.46 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 24.03 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM - 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 101.4 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -377.36 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -0.04 36.72 20 -995.27 127.92 195.85
Price To Operating Cash Flows Ratio TTM -0.04 32.86 16.23 -126.33 144.41 162.25
Price Cash Flow Ratio TTM -0.04 32.86 16.23 -126.33 144.41 162.25
Income Statement (TTM)
VAXX VRTX REGN VRNA ARGX ALNY
Revenue $0B $11.02B $14.34B $0.03B $2.19B $2.25B
Gross Profit $-0B $9.49B $12.24B $0.03B $1.96B $1.92B
Gross Profit Ratio 0% 86.11% 85.35% 93.89% 89.62% 85.62%
EBITDA $-0.05B $0.49B $5.82B $-0.12B $0.11B $-0.18B
Net Income $-0B $-0.54B $4.5B $-0.14B $0.83B $-0.28B
EPS Diluted - -2.08 41.48 -1.73 12.78 -2.18
Balance Sheet (MRQ)
VAXX VRTX REGN VRNA ARGX ALNY
Long Term Debt $0.01B $1.66B $2.71B $0.12B $0.03B $2.59B
Total Liabilities $0.03B $6.12B $9.3B $0.27B $0.7B $4.17B
Total Equity $0.01B $16.41B $31.26B $0.2B $5.5B $0.07B
Total Investments $0.03B $6.65B $15.75B $0.02B $1.93B $1.73B
Total Debt $0.02B $1.75B $2.71B $0.12B $0.04B $2.74B
Total Assets $0.04B $22.53B $40.56B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
VAXX VRTX REGN VRNA ARGX ALNY
Net Income $-0.06B $-0.54B $4.5B $-0.17B $0.83B $-0.28B
Inventory $0B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0.06B $-0.49B $4.98B $-0.12B $-0.08B $-0.01B
Capital Expenditure $-0B $-0.3B $-0.9B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 23.345
AARD Aardvark Therapeutics, Inc. Common Stock 12.27
ABCL AbCellera Biologics Inc. 2.94
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 4.995
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.395
ABPWW 0.0131
ABSI Absci Corporation 2.415
ABUS Arbutus Biopharma Corporation 4.01
ABVC ABVC BioPharma, Inc. 1.67
ABVX Abivax SA American Depositary Shares 124.35
ACAD ACADIA Pharmaceuticals Inc. 21.605
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 6.74
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.13
ACIU AC Immune SA 2.93
ETFs With Exposure to VAXX
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.0002 259.54
VTI Vanguard Total Stock Market Index Fund 0 336.15
IWO iShares Russell 2000 Growth ETF 0.00039 331.155
VXF Vanguard Extended Market Index Fund 0 213.895
HDG ProShares Hedge Replication ETF 0.0000307266 52.7299
UWM ProShares Ultra Russell2000 0.0000698263 51.77
IWC iShares Micro-Cap ETF 0.00126 164.58
URTY ProShares UltraPro Russell2000 0.0000456626 60.85
VTWG Vanguard Russell 2000 Growth Index Fund 0 241.62
VTWO Vanguard Russell 2000 Index Fund 0 104.88
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 115
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 114.98
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 52.53
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 52.52
VBINX Vanguard Balanced Index Fund Investor Shares 0 52.53
VALT ETFMG Sit Ultra Short ETF 0.54 48.52
RYLD Global X Russell 2000 Covered Call ETF 0 15.525
GERM ETFMG Treatments, Testing and Advancements ETF 0.01 19.1577
SILX ETFMG Prime 2x Daily Junior Silver Miners ETF 0.55 1.75
VTSAX Vanguard Total Stock Market Index Fund 0 166.24
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 165.55
VITSX Vanguard Total Stock Market Index Fund 0 166.27
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.0000126388 16.69
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 165.56
SWSSX Schwab Small-Cap Index Fund-Select Shares 0.000212343 42.85
VEMPX Vanguard Extended Market Index InstlPlus 0 408.54
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 311.9
Unlock